Publications by authors named "P Rendo"

Claim this Profile
P
Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B-LONG study.
Beatrice Nolan, Michael Recht, Pablo Rendo, Aletta Falk, Meredith Foster

Eur J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease.
Samuel Lessard, Pauline Rimmelé, Hui Ling, Kevin Moran, Benjamin Vieira, Pablo Rendo

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial.
Manuel Carcao, Michele Schiavulli, Roshni Kulkarni, Pablo Rendo, Meredith Foster

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First open-label, single-arm, prospective study of real-world use of FIX replacement therapy in a predominantly pediatric hemophilia B population in China.
Renchi Yang, Runhui Wu, Jing Sun, Feifei Sun, Jeremy Rupon, Pablo Rendo

Medicine (Baltimore)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-weekly prophylaxis regimen of nonacog alfa in patients with hemophilia B: an analysis of timing of bleeding event onset.
Bartholomew J Tortella, Marcus E Carr, Pablo Rendo, Joan Korth-Bradley, Lynne M Smith

Blood Coagul Fibrinolysis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis